MRP2 expression can be downregulated by alpha-naphthylisothiocyanate (ANIT), ethinylestradiol and other cholestasis-inducing agents or pretreatment with bile duct ligation (Zhang et al., 2016; Yan et al., 2021). The gene discussed is ABCC2; the disease is cholestasis.